Articles tagged with “access”
President Trump's April 2026 executive order accelerating psychedelic research may reshape ketamine's regulatory and clinical landscape. Here's what we know.
An analysis of the unique challenges and innovative solutions for delivering low-dose ketamine therapy to patients in rural and underserved communities, including telehealth models, mobile clinics, and provider training strategies.
Send corrections, provider questions, or advertising inquiries.
